| Psychoeducation (brief) for people with serious mental illness S Zhao, S Sampson, J Xia, MB Jayaram Cochrane Database of Systematic Reviews, 2015 | 176 | 2015 |
| Identifying research priorities for digital technology in mental health care: results of the James Lind Alliance Priority Setting Partnership C Hollis, S Sampson, L Simons, EB Davies, R Churchill, V Betton, ... The Lancet Psychiatry 5 (10), 845-854, 2018 | 160 | 2018 |
| Benzodiazepines for psychosis‐induced aggression or agitation D Gillies, S Sampson, A Beck, J Rathbone Cochrane Database of Systematic Reviews, 2013 | 138* | 2013 |
| The acceptability and usability of digital health interventions for adults with depression, anxiety, and somatoform disorders: qualitative systematic review and meta-synthesis S Patel, A Akhtar, S Malins, N Wright, E Rowley, E Young, S Sampson, ... Journal of Medical Internet Research 22 (7), e16228, 2020 | 112 | 2020 |
| Risperidone versus placebo for schizophrenia RD Rattehalli, S Zhao, BG Li, MB Jayaram, J Xia, S Sampson Cochrane Database of Systematic Reviews, 2016 | 98 | 2016 |
| Family intervention (brief) for schizophrenia U Okpokoro, CE Adams, S Sampson Cochrane Database of Systematic Reviews, 2014 | 97 | 2014 |
| Inpatient forensic-psychiatric care: legal frameworks and service provision in three European countries R Edworthy, S Sampson, B Völlm International journal of law and psychiatry 47, 18-27, 2016 | 95 | 2016 |
| Length of hospitalisation for people with severe mental illness O Babalola, V Gormez, NA Alwan, P Johnstone, S Sampson Cochrane Database of Systematic Reviews, 2014 | 86 | 2014 |
| Depot risperidone for schizophrenia. P Hosalli, JM Davis The Cochrane Database of Systematic Reviews, CD004161-CD004161, 2003 | 85* | 2003 |
| Perphenazine for schizophrenia B Hartung, S Sampson, S Leucht Cochrane database of systematic reviews, 2015 | 84 | 2015 |
| Pimozide for schizophrenia or related psychoses M Mothi, S Sampson Cochrane Database of Systematic Reviews, 2013 | 83* | 2013 |
| Long-term forensic mental health services: an exploratory comparison of 18 European countries S Sampson, R Edworthy, B Völlm, E Bulten International Journal of Forensic Mental Health 15 (4), 333-351, 2016 | 77 | 2016 |
| Intermittent drug techniques for schizophrenia S Sampson, M Mansour, N Maayan, K Soares‐Weiser, CE Adams Cochrane Database of Systematic Reviews, 2013 | 73 | 2013 |
| Sulpiride versus placebo for schizophrenia. IM Omori, J Wang The Cochrane Database of Systematic Reviews, CD007811-CD007811, 2009 | 64* | 2009 |
| Horticultural therapy for schizophrenia Y Liu, B Li, SJ Sampson, S Roberts, G Zhang, W Wu Cochrane Database of Systematic Reviews, 2014 | 62 | 2014 |
| Benzodiazepines for psychosis‐induced aggression or agitation H Zaman, SJ Sampson, ALS Beck, T Sharma, FJ Clay, S Spyridi, S Zhao, ... Cochrane Database of Systematic Reviews, 2017 | 53 | 2017 |
| Elective delivery versus expectant management for pre-eclampsia: a meta-analysis of RCTs Y Wang, M Hao, S Sampson, J Xia Archives of Gynecology and Obstetrics 295, 607-622, 2017 | 52 | 2017 |
| Chlorpromazine versus atypical antipsychotic drugs for schizophrenia KB Saha, L Bo, S Zhao, J Xia, S Sampson, RU Zaman Cochrane Database of Systematic Reviews, 2016 | 48 | 2016 |
| Pharmacy‐based management for depression in adults JVE Brown, N Walton, N Meader, A Todd, LAD Webster, R Steele, ... The Cochrane database of systematic reviews 2019 (12), 2019 | 35 | 2019 |
| Fluphenazine (oral) versus placebo for schizophrenia HE Matar, MQ Almerie, SJ Sampson Cochrane Database of Systematic Reviews, 2018 | 35 | 2018 |
